
zzso necrosis factor therapy has proven effective as treatment against a series of zzso inflammatory diseases, and has displayed a rapidly increasing market zzso The safety profile of these drugs is, however, both uncertain and zzso in particular with respect to infections and zzso Lack of uniform definitions and methods of analysis makes it difficult to directly compare data from zzso controlled trials, zzso of trials, zzso zzso data from spontaneous reporting, and particularly, zzso cohort zzso 

In this review, we provide a summary of currently published data on infection, zzso cardiovascular disease, zzso lung disease, and death in relation to treatment of zzso arthritis with zzso necrosis factor zzso 

zzso contradictory data on infection display a more or less coherent pattern of an increased risk shortly after treatment zzso Available data on zzso cardiovascular disease, zzso lung disease, and death do not exclude clinically important increased risks, nor do they zzso beneficial zzso zzso methods of reporting safety data would greatly improve the interpretation and comparison of class and zzso zzso 

